CANCER IMMUNOTHERAPY (Q3133651): Difference between revisions
Jump to navigation
Jump to search
(Added qualifier: readability score (P590521): 0.0111563501357266) |
(Set a claim value: summary (P836): IMUNOTERAPIA DO CANCRO ATRAVÉS DE ANTIPOS MULTIMÉRICOS BISPECÍFICOS) |
||
Property / summary | Property / summary | ||
IMUNOTERAPIA DO CANCRO ATRAVÉS DE ANTIPOS MULTIMÉRICOS BISPECÍFICOS (Portuguese) |
Revision as of 10:18, 8 October 2024
Project Q3133651 in Spain
Language | Label | Description | Also known as |
---|---|---|---|
English | CANCER IMMUNOTHERAPY |
Project Q3133651 in Spain |
Statements
16,805.25 Euro
0 references
33,610.5 Euro
0 references
50.0 percent
0 references
14 February 2015
0 references
6 February 2017
0 references
LEADARTIS, S.L.
0 references
28008
0 references
INMUNOTERAPIA DEL CÁNCER MEDIANTE ANTICUERPOS MULTIMERICOS BIESPECIFICOS (Spanish)
0 references
IMMUNOTHERAPY OF CANCER THROUGH BISPECIFIC MULTIMERIC ANTIBODIES (English)
0.0111563501357266
0 references
IMMUNOTHÉRAPIE CONTRE LE CANCER À L’AIDE D’ANTICORPS MULTIMÉRIQUES BIESPECIFIC (French)
2 December 2021
0 references
KREBSIMMUNTHERAPIE MIT BIESPECIFIC MULTIMERISCHEN ANTIKÖRPERN (German)
9 December 2021
0 references
KANKERIMMUNOTHERAPIE MET BIESPECIFIC MULTIMEER ANTILICHAMEN (Dutch)
17 December 2021
0 references
IMMUNOTERAPIA TUMORALE CON ANTICORPI MULTIMEDICI BIESPECIFIC (Italian)
16 January 2022
0 references
VÄHI IMMUNOTERAAPIA BISPETSIIFILISTE MULTIMEERSETE ANTIKEHADE KAUDU (Estonian)
4 August 2022
0 references
VĖŽIO IMUNOTERAPIJA PER BISPECIFINIUS MULTIMERINIUS ANTIKŪNUS (Lithuanian)
4 August 2022
0 references
IMUNOTERAPIJA RAKA KROZ DVOSPECIFIČNA MULTIMERIČKA PROTUTIJELA (Croatian)
4 August 2022
0 references
ΑΝΟΣΟΘΕΡΑΠΕΊΑ ΤΟΥ ΚΑΡΚΊΝΟΥ ΜΈΣΩ ΔΙΕΙΔΙΚΏΝ ΠΟΛΥΜΕΡΏΝ ΑΝΤΙΣΩΜΆΤΩΝ (Greek)
4 August 2022
0 references
IMUNOTERAPIA RAKOVINY PROSTREDNÍCTVOM BIŠPECIFICKÝCH MULTIMERICKÝCH PROTILÁTOK (Slovak)
4 August 2022
0 references
SYÖVÄN IMMUNOTERAPIA BISPESIFISTEN MONIMEERISTEN VASTA-AINEIDEN AVULLA (Finnish)
4 August 2022
0 references
IMMUNOTERAPIA RAKA POPRZEZ DWUSPECYFICZNE PRZECIWCIAŁA MULTIMERIC (Polish)
4 August 2022
0 references
A RÁK IMMUNTERÁPIÁJA BISPECIFIKUS MULTIMER ANTITESTEKEN KERESZTÜL (Hungarian)
4 August 2022
0 references
IMUNOTERAPIE RAKOVINY PROSTŘEDNICTVÍM BISPECIFICKÝCH MULTIMERICKÝCH PROTILÁTEK (Czech)
4 August 2022
0 references
VĒŽA IMŪNTERAPIJA AR BISPECIFISKĀM MULTIMĒRĀM ANTIVIELĀM (Latvian)
4 August 2022
0 references
IMDHÍONTEIRIPE AILSE TRÍ ANTASUBSTAINTÍ ILMHÉIREACHA DÉSHONRACHA (Irish)
4 August 2022
0 references
IMUNOTERAPIJA RAKA Z DVOSPECIFIČNIMI MULTIMERNIMI PROTITELESI (Slovenian)
4 August 2022
0 references
ИМУНОТЕРАПИЯ НА РАК ЧРЕЗ ДВУСПЕЦИФИЧНИ МУЛТИМЕРНИ АНТИТЕЛА (Bulgarian)
4 August 2022
0 references
IMMUNOTERAPIJA TAL-KANĊER PERMEZZ TA’ ANTIKORPI MULTIMERIĊI BISPEĊIFIĊI (Maltese)
4 August 2022
0 references
IMUNOTERAPIA DO CANCRO ATRAVÉS DE ANTIPOS MULTIMÉRICOS BISPECÍFICOS (Portuguese)
4 August 2022
0 references
IMMUNTERAPI AF KRÆFT GENNEM BISPECIFIKKE MULTIMERISKE ANTISTOFFER (Danish)
4 August 2022
0 references
IMUNOTERAPIA CANCERULUI PRIN ANTICORPI MULTIMERICI BISPECIFICI (Romanian)
4 August 2022
0 references
IMMUNTERAPI AV CANCER GENOM BISPECIFIKA MULTIMERA ANTIKROPPAR (Swedish)
4 August 2022
0 references
Madrid
0 references
21 December 2023
0 references
Identifiers
DGEPF/01/21/002-17/13
0 references